-
1
-
-
69249089353
-
Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research
-
Anderson C.J., Ferdani R. Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. Cancer Biother. Radiopharm. 2009, 24:379-393.
-
(2009)
Cancer Biother. Radiopharm.
, vol.24
, pp. 379-393
-
-
Anderson, C.J.1
Ferdani, R.2
-
2
-
-
53749095638
-
18F-FDG PET to medicine over 3 decades
-
18F-FDG PET to medicine over 3 decades. J. Nucl. Med. 2008, 49(17N-21N):37N.
-
(2008)
J. Nucl. Med.
, vol.49
, Issue.37
, pp. 17N-21N
-
-
Basu, S.1
Alavi, A.2
-
3
-
-
77951474500
-
89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer
-
89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin. Pharmacol. Ther. 2010, 87:586-592.
-
(2010)
Clin. Pharmacol. Ther.
, vol.87
, pp. 586-592
-
-
Dijkers, E.C.1
Oude Munnink, T.H.2
Kosterink, J.G.3
Brouwers, A.H.4
Jager, P.L.5
de Jong, J.R.6
van Dongen, G.A.7
Schroder, C.P.8
Lub-de Hooge, M.N.9
de Vries, E.G.10
-
4
-
-
84929493114
-
68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy
-
68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy. J. Nucl. Med. 2015, 56:668-674.
-
(2015)
J. Nucl. Med.
, vol.56
, pp. 668-674
-
-
Eiber, M.1
Maurer, T.2
Souvatzoglou, M.3
Beer, A.J.4
Ruffani, A.5
Haller, B.6
Graner, F.P.7
Kubler, H.8
Haberhorn, U.9
Eisenhut, M.10
Wester, H.J.11
Gschwend, J.E.12
Schwaiger, M.13
-
5
-
-
84859990896
-
18F]fluoro-deoxy-glucose folate: a novel PET radiotracer with improved in vivo properties for folate receptor targeting
-
18F]fluoro-deoxy-glucose folate: a novel PET radiotracer with improved in vivo properties for folate receptor targeting. Bioconjug. Chem. 2012, 23:805-813.
-
(2012)
Bioconjug. Chem.
, vol.23
, pp. 805-813
-
-
Fischer, C.R.1
Müller, C.2
Reber, J.3
Müller, A.4
Kramer, S.D.5
Ametamey, S.M.6
Schibli, R.7
-
6
-
-
34248529824
-
3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT
-
3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J. Nucl. Med. 2007, 48:508-518.
-
(2007)
J. Nucl. Med.
, vol.48
, pp. 508-518
-
-
Gabriel, M.1
Decristoforo, C.2
Kendler, D.3
Dobrozemsky, G.4
Heute, D.5
Uprimny, C.6
Kovacs, P.7
Von Guggenberg, E.8
Bale, R.9
Virgolini, I.J.10
-
7
-
-
44249086423
-
Production and separation of ''non-standard'' PET nuclides at a large cyclotron facility: the experiences at the Paul Scherrer Institute in Switzerland
-
Hohn A., Zimmermann K., Schaub E., Hirzel W., Schubiger P.A., Schibli R. Production and separation of ''non-standard'' PET nuclides at a large cyclotron facility: the experiences at the Paul Scherrer Institute in Switzerland. Q. J. Nucl. Med. Mol. Imaging 2008, 52:145-150.
-
(2008)
Q. J. Nucl. Med. Mol. Imaging
, vol.52
, pp. 145-150
-
-
Hohn, A.1
Zimmermann, K.2
Schaub, E.3
Hirzel, W.4
Schubiger, P.A.5
Schibli, R.6
-
8
-
-
84877845352
-
44Sc for clinical application
-
44Sc for clinical application. Radiochim. Acta 2013, 101:333-338.
-
(2013)
Radiochim. Acta
, vol.101
, pp. 333-338
-
-
Krajewski, S.1
Cydzik, I.2
Abbas, K.3
Bulgheroni, A.4
Simonelli, F.5
Holzwarth, U.6
Bilewicz, A.7
-
9
-
-
84862576530
-
Can PET imaging facilitate optimization of cancer therapies?
-
Kramer-Marek G., Capala J. Can PET imaging facilitate optimization of cancer therapies?. Curr. Pharm. Des. 2012, 18:2657-2669.
-
(2012)
Curr. Pharm. Des.
, vol.18
, pp. 2657-2669
-
-
Kramer-Marek, G.1
Capala, J.2
-
10
-
-
44249097810
-
Image quality with non-standard nuclides in PET
-
Laforest R., Liu X. Image quality with non-standard nuclides in PET. Q. J. Nucl. Med. Mol. Imaging 2008, 52:151-158.
-
(2008)
Q. J. Nucl. Med. Mol. Imaging
, vol.52
, pp. 151-158
-
-
Laforest, R.1
Liu, X.2
-
11
-
-
67349166962
-
Quantitative small animal PET imaging with nonconventional nuclides
-
Liu X., Laforest R. Quantitative small animal PET imaging with nonconventional nuclides. Nucl. Med. Biol. 2009, 36:551-559.
-
(2009)
Nucl. Med. Biol.
, vol.36
, pp. 551-559
-
-
Liu, X.1
Laforest, R.2
-
12
-
-
58949090833
-
Positron emission tomography/computed tomography: the current technology and applications
-
Mittra E., Quon A. Positron emission tomography/computed tomography: the current technology and applications. Radiol. Clin. N. Am. 2009, 47:147-160.
-
(2009)
Radiol. Clin. N. Am.
, vol.47
, pp. 147-160
-
-
Mittra, E.1
Quon, A.2
-
13
-
-
84883143252
-
Radiolabeling and in vitro/in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor
-
Mu L., Bieri D., Slavik R., Drandarov K., Müller A., Cermak S., Weber M., Schibli R., Kramer S.D., Ametamey S.M. Radiolabeling and in vitro/in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor. J. Neurochem. 2013, 126:616-624.
-
(2013)
J. Neurochem.
, vol.126
, pp. 616-624
-
-
Mu, L.1
Bieri, D.2
Slavik, R.3
Drandarov, K.4
Müller, A.5
Cermak, S.6
Weber, M.7
Schibli, R.8
Kramer, S.D.9
Ametamey, S.M.10
-
14
-
-
84878156723
-
68Ga-DOTA-TATE
-
68Ga-DOTA-TATE. Appl. Radiat. Isot. 2013, 76:63-69.
-
(2013)
Appl. Radiat. Isot.
, vol.76
, pp. 63-69
-
-
Mu, L.1
Hesselmann, R.2
Oezdemir, U.3
Bertschi, L.4
Blanc, A.5
Dragic, M.6
Löffler, D.7
Smuda, C.8
Johayem, A.9
Schibli, R.10
-
15
-
-
84893351486
-
44Sc-DOTA-folate conjugate
-
44Sc-DOTA-folate conjugate. J. Nucl. Med. 2013, 54:2168-2174.
-
(2013)
J. Nucl. Med.
, vol.54
, pp. 2168-2174
-
-
Müller, C.1
Bunka, M.2
Reber, J.3
Fischer, C.4
Zhernosekov, K.5
Türler, A.6
Schibli, R.7
-
16
-
-
29144503212
-
Modeling and simulation of positron range effects for high resolution PET imaging
-
Palmer M.R., Zhu X., Parker A. Modeling and simulation of positron range effects for high resolution PET imaging. IEEE Trans. Nucl. Sci. 2005, 52:1391-1395.
-
(2005)
IEEE Trans. Nucl. Sci.
, vol.52
, pp. 1391-1395
-
-
Palmer, M.R.1
Zhu, X.2
Parker, A.3
-
17
-
-
41849104653
-
PET versus SPECT: strengths, limitations and challenges
-
Rahmim A., Zaidi H. PET versus SPECT: strengths, limitations and challenges. Nucl. Med. Commun. 2008, 29:193-207.
-
(2008)
Nucl. Med. Commun.
, vol.29
, pp. 193-207
-
-
Rahmim, A.1
Zaidi, H.2
-
18
-
-
84863557485
-
44Sc generator system
-
44Sc generator system. Curr. Radiopharm. 2012, 5:187-201.
-
(2012)
Curr. Radiopharm.
, vol.5
, pp. 187-201
-
-
Roesch, F.1
-
20
-
-
84937727958
-
44Sc: from bench to bedside
-
44Sc: from bench to bedside. Nucl. Med. Biol. 2015, 42:745-751.
-
(2015)
Nucl. Med. Biol.
, vol.42
, pp. 745-751
-
-
van der Meulen, N.P.1
Bunka, M.2
Domnanich, K.A.3
Müller, C.4
Haller, S.5
Vermeulen, C.6
Türler, A.7
Schibli, R.8
-
21
-
-
34247229328
-
Performance evaluation of the GE healthcare eXplore VISTA dual-ring small-animal PET scanner
-
Wang Y., Seidel J., Tsui B.M., Vaquero J.J., Pomper M.G. Performance evaluation of the GE healthcare eXplore VISTA dual-ring small-animal PET scanner. J. Nucl. Med. 2006, 47:1891-1900.
-
(2006)
J. Nucl. Med.
, vol.47
, pp. 1891-1900
-
-
Wang, Y.1
Seidel, J.2
Tsui, B.M.3
Vaquero, J.J.4
Pomper, M.G.5
|